All Stories

  1. Anticancer drug discovery using multicellular tumor spheroid models
  2. DNA ploidy and S-phase fraction analysis in peritoneal carcinomatosis from ovarian cancer: correlation with clinical pathological factors and response to chemotherapy
  3. Cancer multicellular spheroids: Volume assessment from a single 2D projection
  4. Albumin nanocapsules containing fenretinide: pre-clinical evaluation of cytotoxic activity in experimental models of human non-small cell lung cancer
  5. Improving reliability of live/dead cell counting through automated image mosaicing
  6. Accelerated Hypofractionated Radiation Therapy Plus Chemotherapy for Inoperable Locally Advanced Lung Cancer: Final Results of Long-term Follow-up
  7. Image processing method for 3D volume rendering from one 2D projection: Application to Cancer spheroids
  8. Locoregional Hypofractionated Radio-Chemotherapy for Unresectable Nonmetastatic Pancreatic Cancer
  9. Accelerated Hypofractionated Radiation Therapy Plus Chemotherapy for Inoperable Locally Advanced Lung Cancer: Final Results of Long-Term Follow-up
  10. Silencing of mitochondrial Lon protease deeply impairs mitochondrial proteome and function in colon cancer cells
  11. Efficacy of Different Sequences of Radio- and Chemotherapy in Experimental Models of Human Melanoma
  12. Prolonged exposure to (R)-bicalutamide generates a LNCaP subclone with alteration of mitochondrial genome
  13. In vitro irradiation system for radiobiological experiments
  14. Hypofractionated Chemoradiation Therapy With Gemcitabine Plus Oxaliplatin for Unresectable Nonmetastatic Locally-Advanced Pancreatic Cancer
  15. Role of Conventional Chemosensitivity Test and Tissue Biomarker Expression in Predicting Response to Treatment of Peritoneal Carcinomatosis From Colon Cancer
  16. Effect of Small Molecules Modulating Androgen Receptor (SARMs) in Human Prostate Cancer Models
  17. SLUG silencing increases radiosensitivity of melanoma cells in vitro
  18. Specific Biomarkers Are Associated with Docetaxeland Gemcitabine-Resistant NSCLC Cell Lines
  19. Extended depth of focus in optical microscopy: Assessment of existing methods and a new proposal
  20. Organosulfur derivatives of the HDAC inhibitor valproic acid sensitize human lung cancer cell lines to apoptosis and to cisplatin cytotoxicity
  21. Inhibition of breast cancer cell proliferation in repeated and non-repeated treatment with zoledronic acid
  22. Activity of different anthracycline formulations in hormone-refractory prostate cancer cell lines: Role of golgi apparatus
  23. Low-dose taxotere enhances the ability of sorafenib to induce apoptosis in gastric cancer models
  24. Peritoneal carcinomatosis from ovarian cancer: chemosensitivity test and tissue markers as predictors of response to chemotherapy
  25. In Vitro and In Vivo Antitumor Efficacy of Docetaxel and Sorafenib Combination in Human Pancreatic Cancer Cells
  26. In Vitro and In Vivo Antitumor Efficacy of Docetaxel and Sorafenib Combination in Human Pancreatic Cancer Cells
  27. Assessment Of K-ras And Epidermal Growth Factor (EGFR) Receptor Mutation By Transesophageal Ultrasound-guided Fine Needle Aspiration (EUS-FNA)
  28. Abstract 2709: Peritoneal carcinomatosis from ovarian cancer: tissue markers as predictors of response to chemotherapy
  29. Abstract A83: Liposomal doxorubicin induces Golgi-dependent apoptosis in hormone-refractory prostate cancer cell lines (HRPC)
  30. Role of efflux pump activity in lapatinib/caelyx combination in breast cancer cell lines
  31. Docetaxel-ST1481 sequence exerts a potent cytotoxic activity on hormone-resistant prostate cancer cells by reducing drug resistance-related gene expression
  32. Role of RAF/MEK/ERK pathway, p-STAT-3 and Mcl-1 in sorafenib activity in human pancreatic cancer cell lines
  33. Isolation of stem/progenitor cells from normal lung tissue of adult humans
  34. Activity of lipoplatin in tumor and in normal cells in vitro
  35. Mitotic catastrophe and apoptosis induced by docetaxel in hormone-refractory prostate cancer cells
  36. NCX 4040, an NO-donating acetylsalicylic acid derivative: Efficacy and mechanisms of action in cancer cells
  37. Role of p53 Codon 72 Arginine Allele in Cell Survival in vitro and in the Clinical Outcome of Patients with Advanced Breast Cancer
  38. Zoledronic acid increases docetaxel cytotoxicity through pMEK and Mcl-1 inhibition in a hormone-sensitive prostate carcinoma cell line
  39. Comparative evaluation of C1311 cytotoxic activity and interference with cell cycle progression in a panel of human solid tumour and leukaemia cell lines
  40. Phase I Study of Paclitaxel and Uracil plus Tegafur Combination in Patients with Pretreated Metastatic Breast Cancer: Drug Sequencing Based on Preclinical Modelling Studies
  41. Study of molecular mechanisms of pro-apoptotic activity of NCX 4040, a novel nitric oxide-releasing aspirin, in colon cancer cell lines
  42. Iressa strengthens the cytotoxic effect of docetaxel in NSCLC models that harbor specific molecular characteristics
  43. B11. Efficacy and mechanism of action of NCX 4040, a NO-donating acetyl salicylic acid derivative, as anticancer drug or sensitizing agent of conventional chemotherapeutic agents
  44. Molecular characterization of cytotoxic and resistance mechanisms induced by NCX 4040, a novel NO-NSAID, in pancreatic cancer cell lines*
  45. Modulation of drug cytotoxicity by iressa (ZD1839) in pancreatic cancer cell lines
  46. Pro-apoptotic effect of a nitric oxide-donating NSAID, NCX 4040, on bladder carcinoma cells
  47. Innovative sequence of docetaxel–gemcitabine based on preclinical data in the treatment of advanced non small cell lung cancer: a phase I study
  48. Cellular Basis of Antiproliferative and Antitumor Activity of the Novel Camptothecin Derivative, Gimatecan, in Bladder Carcinoma Models
  49. p16INK4A andCDH13 hypermethylation in tumor and serum of non-small cell lung cancer patients
  50. 222 P53-mediated apoptosis induced by NCX 4040, a nitric oxide-releasing aspirin derivative, in human colon cancer cell lines
  51. 232 In vitro and in vivo antitumor efficacy of NCX-4040, a nitric oxide-releasing non-steroidal anti-inflammatory drug, in combination with antineoplastic drugs on human colon cancer lines
  52. Schedule-Dependent Cytotoxic Interaction between Epidoxorubicin and Gemcitabine in Human Bladder Cancer Cells in Vitro
  53. NCX 4016, a nitric oxide-releasing aspirin derivative, exhibits a significant antiproliferative effect and alters cell cycle progression in human colon adenocarcinoma cell lines
  54. Flow-Cytometric Determination of Tumor Cells in Lymph Nodes1
  55. In vitro preclinical models for a rational design of chemotherapy combinations in human tumors
  56. Lanreotide-Induced Modulation of 5-Fluorouracil or Mitomycin C Cytotoxicity in Human Colon Cancer Cell Lines: a Preclinical Study